Targeting hypoxia-inducible factor-2α enhances sorafenib antitumor activity via β-catenin/C-Myc-dependent pathways in hepatocellular carcinoma

Feng Liu(Shandong Provincial QianFoShan Hospital), Jie Li(Shandong Provincial QianFoShan Hospital)
Oncology Letters
June 3, 2015
Cited by 34


Related Papers